CN101391069A - Traditional Chinese medicine for treating tuberculosis - Google Patents

Traditional Chinese medicine for treating tuberculosis Download PDF

Info

Publication number
CN101391069A
CN101391069A CNA200810175850XA CN200810175850A CN101391069A CN 101391069 A CN101391069 A CN 101391069A CN A200810175850X A CNA200810175850X A CN A200810175850XA CN 200810175850 A CN200810175850 A CN 200810175850A CN 101391069 A CN101391069 A CN 101391069A
Authority
CN
China
Prior art keywords
medicine
chinese medicine
tuberculosis
treatment
chinese traditional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA200810175850XA
Other languages
Chinese (zh)
Other versions
CN101391069B (en
Inventor
曹文波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810175850XA priority Critical patent/CN101391069B/en
Publication of CN101391069A publication Critical patent/CN101391069A/en
Application granted granted Critical
Publication of CN101391069B publication Critical patent/CN101391069B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a Chinese traditional medicine for curing phthisic, which aim at solving the problems of strong side effects and low recovery ratio in prior art. The medicine is composed of following materials: caladium 70 to 90, tokay 70 to 90, deglued antler 130 to 170, Radix Stemonae 80 to 120, rhizome of twoleaf platanthera 70 to 90, turtle shell 130 to 170 and Japanese hop 130 to 170. Adopting rare Chinese traditional medicines preparation, the Chinese traditional medicine is provided with effects of supplementing bone, generating muscle, moistening lung, stopping blooding, promoting recovery and strengthening the body constitution; and can be used for curing various tuberculosis without side effect and medicine resistance; thus solving the problem of poor curative effect and no recovery by pure western medicine.

Description

Treat Chinese medicine lungy
Technical field
The present invention relates to a kind of treatment Chinese medicine lungy.
Background technology
Tuberculosis is first killer in present adult's infectious disease, and according to World Health Organization (WHO): China has active tuberculosis patient 2,000,000 now, only is lower than India and occupies the second place of the world.Tuberculosis is a kind of wasting diseases, if do not cause patient and medical worker's attention, often delays the state of an illness because of tuberculosis patient lacks specific symptom.
The tuberculosis traditional Chinese medical science is called " consumptive disease ", it is to invade a kind of stubbornness, the course of disease that cause behind the human body long, easily drug resistance, easily recurrence, chronic infectious disease that mortality rate is high by tubercule bacillus, cure very difficultly, patient Chang Yin tuberculosis Western medicine produces after toxicity or the medication and to make after inefficacy or DeGrain (drug resistance) therapy discontinued that sb.'s illness took a turn for the worse so that loss of life.
Summary of the invention
For overcoming above-mentioned defective, the object of the present invention is to provide a kind of having no side effect, the treatment that cure rate is high Chinese medicine lungy.
For achieving the above object, the present invention treats Chinese medicine lungy, comprises the raw material of following weight parts:
Bulbus Fritillariae Uninbracteatae 70-90 Gecko 70-90 Cornu Cervi Degelatinatum 130-170
Radix Stemonae (processed) 80-120 Pseudobulbus Bletillae (Rhizoma Bletillae) 70-90 Carapax Trionycis 130-170
Herba humuli scandentis 130-170.
Further, the raw material that also comprises following weight parts:
Radix Ophiopogonis 70-90 Bulbus Lilii 60-80 Cordyceps 25-35.
Wherein, the weight portion of described raw material is specially:
Bulbus Fritillariae Uninbracteatae 80 Geckos 90 Cornu Cervi Degelatinatums 150 Radix Stemonae (processed) 100
150 Radix Ophiopogonis 80 of the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 Carapax Trionycis 150 Herba humuli scandentis
Bulbus Lilii 70 Cordyceps 30.
The invention described above Chinese medicine lungy, the preparation of employing rare Chinese medicine has effects such as the bone of benefit, granulation promoting, lung moistening, hemostasis, promotion healing, health invigorating, is used for the treatment of various tuberculosis to have no side effect, have no drug resistance, solved some patients and used Western medicine weak curative effect and incurable problem merely.
The specific embodiment
Below in conjunction with embodiment the present invention is described further.
A kind of treatment of the present invention Chinese medicine lungy, form by following raw material:
Bulbus Fritillariae Uninbracteatae 70-90 Gecko 70-90 Cornu Cervi Degelatinatum 130-170
Radix Stemonae (processed) 80-120 Pseudobulbus Bletillae (Rhizoma Bletillae) 70-90 Carapax Trionycis 130-170
Herba humuli scandentis 130-170.
Better, also comprise
Radix Ophiopogonis 70-90 Bulbus Lilii 60-80 Cordyceps 25-35.
Increase and decrease in how many above-mentioned scopes that do not coexist according to patient's the difference and the state of an illness of above-mentioned raw material use amount, effect is better.
Embodiment 1
A kind of treatment of the present invention Chinese medicine lungy is made up of the raw material of following weight parts: Bulbus Fritillariae Uninbracteatae 75 Geckos 80 Cornu Cervi Degelatinatums 140 Radix Stemonae (processed) 90 Pseudobulbus Bletillae (Rhizoma Bletillae)s 80 Carapax Trionycis 140 Herba humuli scandentis 150.
Embodiment 2
A kind of treatment of the present invention Chinese medicine lungy, form by the raw material of following weight parts:
Bulbus Fritillariae Uninbracteatae 90 Geckos 80 Cornu Cervi Degelatinatums 130 Radix Stemonae (processed) 120
150 Radix Ophiopogonis 70 of the Pseudobulbus Bletillae (Rhizoma Bletillae) 70 Carapax Trionycis 130 Herba humuli scandentis
Bulbus Lilii 80 Cordyceps 30.
Use through reality, the embodiment of effect optimum is:
Bulbus Fritillariae Uninbracteatae 80 Geckos 90 Cornu Cervi Degelatinatums 150 Radix Stemonae (processed) 100
150 Radix Ophiopogonis 80 of the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 Carapax Trionycis 150 Herba humuli scandentis
Bulbus Lilii 70 Cordyceps 30.
Manufacture method:
Above picking of raw material, removal of contamination and non-medicinal part are crossed No. 6 sieves for smalls and are incapsulated after being mixed and get final product (the medicated powder net weight in every capsules about 0.4 restrains).
Usage and dosage:
Oral each 8 (heavily suffer from and can obey 10) day clothes twice, take half an hour ante cibum, and under-16 patient is cut down according to the circumstance, (two months is a course of treatment).
Function cures mainly:
Mend bone, granulation promoting, lung moistening, hemostasis, evacuation of pus blood stasis dispelling, promote healing, health invigorating, be used for the treatment of various tuberculosis.
The Chinese medicine of the present invention that is made into optimum embodiment (is called in the following text: above-mentioned prescription) be example, in conjunction with following case, the present invention be further described below.
Case 1
Patient Ning Wenli, 25 years old, woman, peasant, address: ice ditch village, lama hole, Jianchang County, Huludao City town
This patient suffers from heavy pulmonary tuberculosis, after the Purple Mountain, Jinzhou tuberculosis hospitalize 2 months is invalid, come my institute to cooperate above-mentioned prescription on August 17th, 99 with isoniazid, rifampin, effective after January, life can be taken care of oneself after February, back continuous use 3 months, patient's complete recovery of health is now worked in the restaurant, Shenyang.
Case 2
Patient Ji Xiaoqin, 23 years old, the woman, the peasant, the address: cavernous pulmonary tuberculosis is suffered from female Dou Yingzi village, lama hole, Jianchang County town, after county institute of traditional Chinese medicine fails to respond to any medical treatment, go to BJ Chest Science Hospital again, be with 2 months medicines to return, invalid with the back, come my institute's treatment 98 October 3 noon, with Western medicine isoniazid, rifampicin and above-mentioned prescription, take effect with back 1 month, symptom was clearly better in 2 months, substantially disappear the focus calcification with sign after month again.Now be mother of 2 children, can have participated in various productive labors.
Case 3
Patient Chen Ming, 39 years old, man, peasant.Address: cockscomb mountain area, Fengcheng City county Chinese cabbage ground village.
Patient's waist 1,2 tuberculosis of spine, in county hospital, Fengcheng City 4 months surplus, the state of an illness increases the weight of, cold abscess appears in femoribus internus, wears out to come to a head.Come my institute's treatment November 5 nineteen ninety-five, see the X-ray sheet, the visible worm food of waist 1,2 vertebral bodys sample destruction region has wedge shape to change, narrowing of intervertebral space, / X side psoas major has fusiformis soft lump shadow, and diagnosis waist 1,2 vertebra tuberculosis cooperate rifampicin, isoniazid oral two and half behind the door with above-mentioned prescription, the sinus tract healing, the other lump shadow of organizing of x mating plate vertebra disappears, and the vertebral body bone density increases, and is the bone fusion.
Case 4
Patient Wang Baiwen, 51 years old, the man, the peasant has the pulmonary tuberculosis medical history.Address: Yingkou City Spanish mackerel circle town.
This patient did the appendicitis excision in Yingkou City hospital, and postoperative wound 3 months is healing not, and was through Yingkou City's tuberculosis hospital antituberculosis therapy 1 year, invalid again.
Come my institute to go to a doctor on March 7th, 1998,, examine and be tuberculous peritonitis, cooperated above-mentioned prescription oral two months, behind the wound healing, consolidate medication 4 months again, follow up a case by regular visits to and fully recover with tuberculosis Western medicine isoniazid according to the wound situation.
Above-mentioned the present invention treats the Chinese medicine of tuberculosis, has the bone of benefit granulation promoting, lung moistening hemostasis, evacuation of pus blood stasis dispelling, promotes healing, constitutional effect.Surplus clinical ten year, treat various tuberculosis examples up to a hundred, wherein,
Pulmonary tuberculosis: treat 172 examples, effective 168 examples, effective percentage reaches 97.7%; Cure 156 examples, cure rate reaches 90.7%, and invalid 4 examples account for sum 2.3%.
Bone tuberculosis: treat 51 examples, produce effects 49 examples, effective percentage reaches 96.17%; Cure 48 examples, cure rate reaches 94.1%, and invalid 2 examples account for sum 3.9%.
Tuberculous pleuritis: treat 49 examples, produce effects 44 examples, effective percentage reaches 93.6%; Cure 40 examples, cure rate reaches 85.1%, and invalid 3 examples account for sum 6.3%.
Tuberculous peritonitis: treat 29 examples, produce effects 29 examples, effective percentage reaches 100%; Cure 28 examples, cure rate reaches 96.6%, and invalid is 0.
Through summing up in the clinical practice for many years, the present invention treats the Chinese medicine of tuberculosis can plant tuberculosis in Zhiduo County, and has no side effect, and no drug resistance has solved some patients and used Western medicine weak curative effect and incurable problem merely.The bone tuberculosis bone destruction is serious to form a plurality of fistulas road also it goes without doing bone grafting operation, pulmonary tuberculosis, tuberculous pleuritis, tuberculous peritonitis, curelessly still can cure, satisfactory therapeutic effects (other tuberculosis is also the had certain curative effect) total effective rate that also can reach very that is not easy to recover late period has been cured national people and has been measured the patient up to 98%.The patient takes medicine and just begins to take effect in one month, after take a turn for the better gradually, symptom disappeared substantially in two months, the check of x line, diseased region begins to have and absorbs or calcification, one all can be fully recovered in six or seven month.This medicine reasonable recipe, dose is suitable, and treatment tuberculosis is effective.

Claims (3)

1, a kind of treatment Chinese medicine lungy is characterized in that, comprises the raw material of following weight parts:
Bulbus Fritillariae Uninbracteatae 70-90 Gecko 70-90 Cornu Cervi Degelatinatum 130-170
Radix Stemonae (processed) 80-120 Pseudobulbus Bletillae (Rhizoma Bletillae) 70-90 Carapax Trionycis 130-170
Herba humuli scandentis 130-170.
2, treatment as claimed in claim 1 Chinese medicine lungy is characterized in that, also comprises the raw material of following weight parts:
Radix Ophiopogonis 70-90 Bulbus Lilii 60-80 Cordyceps 25-35.
3, treatment as claimed in claim 1 Chinese medicine lungy is characterized in that, the weight portion of described raw material is specially:
Bulbus Fritillariae Uninbracteatae 80 Geckos 90 Cornu Cervi Degelatinatums 150 Radix Stemonae (processed) 100
150 Radix Ophiopogonis 80 of the Pseudobulbus Bletillae (Rhizoma Bletillae) 80 Carapax Trionycis 150 Herba humuli scandentis
Bulbus Lilii 70 Cordyceps 30.
CN200810175850XA 2008-11-05 2008-11-05 Traditional Chinese medicine for treating tuberculosis Expired - Fee Related CN101391069B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810175850XA CN101391069B (en) 2008-11-05 2008-11-05 Traditional Chinese medicine for treating tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810175850XA CN101391069B (en) 2008-11-05 2008-11-05 Traditional Chinese medicine for treating tuberculosis

Publications (2)

Publication Number Publication Date
CN101391069A true CN101391069A (en) 2009-03-25
CN101391069B CN101391069B (en) 2010-11-03

Family

ID=40491710

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810175850XA Expired - Fee Related CN101391069B (en) 2008-11-05 2008-11-05 Traditional Chinese medicine for treating tuberculosis

Country Status (1)

Country Link
CN (1) CN101391069B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104225399A (en) * 2014-09-05 2014-12-24 胡健 Traditional Chinese medicine for treating pulmonary tuberculosis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107412267A (en) * 2017-08-15 2017-12-01 李道前 One kind treats Chinese medicine lungy and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046421C (en) * 1996-04-01 1999-11-17 李廷俊 Drug for curing pulmonary tuberculosis
CN1124151C (en) * 2001-10-11 2003-10-15 刘伟东 Medicine for treating tuberculosis
CN1186075C (en) * 2002-12-30 2005-01-26 方文理 Medicines for treating pulmonary tuberculosis
CN1879668A (en) * 2006-05-12 2006-12-20 成都市武侯专利咨询研发转化研究所 Medicine for treating pulmonary tuberculosis
CN101129906B (en) * 2007-08-22 2010-08-04 王芬 Orally taken traditional Chinese medicine composition for treating tuberculosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104225399A (en) * 2014-09-05 2014-12-24 胡健 Traditional Chinese medicine for treating pulmonary tuberculosis

Also Published As

Publication number Publication date
CN101391069B (en) 2010-11-03

Similar Documents

Publication Publication Date Title
CN101703708B (en) Chinese medicinal preparation for treating rheumatoid arthritis and gout, and preparation method thereof
CN101352505B (en) Bone fracture setting medicine powder for treating traumatic injury
CN101391069B (en) Traditional Chinese medicine for treating tuberculosis
CN101342290B (en) Tong bi liquid and preparation method thereof
CN105213321A (en) Medicinal-bathing particle agent of a kind of arteannuin or derivatives thereof and uses thereof
CN101406633A (en) Pellet for recuperation of neck and waist
CN100534450C (en) Chinese medicinal formulation for treating rheumatic and rheumatoid arthritis and preparation process thereof
CN102552843B (en) Medicament composite for curing osteoarthropathy
CN103301215B (en) Pharmaceutical composition for treating bone disease as well as preparation method and use thereof
CN106110124A (en) A kind of antituberculotic Chinese medicine composition
CN101596297B (en) Tinea-curing pill
CN105412206A (en) Traditional Chinese medicine preparation with relaxing tendon and dissipating hard mass effects
CN101264160B (en) Bone-setting and pain-relieving Chinese medicine composition and preparation thereof
CN108272850A (en) A kind of thrombolytic drug and preparation method thereof
CN1562117A (en) Chinese medicinal preparation for quick bone fracture setting
CN103893436B (en) A kind of externally applied drug for treating rheumatism
CN1233394C (en) Reumatic arthritis treating medicine
CN102178758A (en) Medicament for treating peripheral nerve of diabetes
CN102258762B (en) Medicinal composition for diminishing swelling and relieving pain and preparation and use thereof
CN1272053C (en) Chinese medicine for treating tuberculosis and its prepn and use
CN102961520B (en) Pharmaceutical composition for treating arthritis and method for preparing pharmaceutical composition for treating arthritis
CN105327284B (en) A kind of externally applied drug and preparation method thereof for treating children's hip synovitis
CN101168035B (en) External-applied medicine for treating hyperosteogeny
CN111514189A (en) A pharmaceutical composition for treating sciatica and its preparation method
CN1117853A (en) Traditional Chinese medicinal composite for curing angioma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101103

Termination date: 20171105